Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial

Sujata Kar, Sujata Kar

Abstract

Objective: To compare Letrozole (5 mg) and clomiphene citrate (100 mg) as first line ovulation induction drug in infertile PCOS women.

Study design: Prospective Randomised trial.

Setting: A Tertiary level infertility centre.

Patients: 103 infertile PCOS women.

Interventions: Treatment naïve infertile PCOS women were randomised to treatment with 5 mg letrozole (51 patients) or 100 mg clomiphene citrate (52 patients) daily starting day 2 to day 6 of menstrual cycle. Timed intercourse or Intra Uterine Insemination (IUI) was advised 24 to 36 hours after Human Chorionic Gonadotropin (HCG) injection.

Main outcome measures: Ovulation rate, mono or multi follicular rate, days to ovulation, endometrial thickness, serum progesterone, serum estrogen, pregnancy rate, miscarriage rate.

Results: The mean age, Body Mass Index (BMI), duration of infertility in both Clomiphene Citrate (CC) and Letrozole groups were similar.Ovulation rate was 73.08% in letrozole group and 60.78% in CC, which was not statistically significant (P=0.398). There was no statistically significant difference between Endometrial thickness (CC 7.61 ±1.96, Let 7.65 ± 2.10), Sr E2 on day of HCG (CC 178.3 ± 94.15, Let 162.09 ± 73.24), Days to ovulation (CC 14.2 ± 3.41; Let 13.13 ± 2.99) and Sr P4 on D21 (CC 10.58 ± 6.65; Let 11.86 ± 6.51). Monofolliculo genesis (CC 54.84, Let 79.49 %, P=0.027) and Pregnancy rate (CC 7.84%, Let 21.56% P=0.0125) were statistically significantly higher in letrozole group.

Conclusion: Our study shows that letrozole has excellent pregnancy rates compared to clomiphene citrate. Letrozole should be considered at par with clomiphene citrate as first line drug for ovulation induction in infertile PCOS women.

Keywords: Clomiphene citrate; PCOS; letrozole; ovulation induction.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2001;41:65–8.
    1. Guzick D. Polycystic ovary syndrome, symptolatology, pathophysiology and epidemiology. Am J Obstet Gynecol. 1998;179:89–93.
    1. Slowey MJ. Polycystic ovary syndrome: New perspective on an old problem. South Med J. 2001;94:190–5.
    1. Casper RF. Letrozole versus clomiphene citrate: Which is better for ovulation induction? Fertil Steril. 2009;92:858–9.
    1. Amsterdam ESHRE/ASRM – Sponsored 3rd PCOS consensus workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS) Hum Reprod. 2012;27:14–24.
    1. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol. 1985;12:605–32.
    1. Kistner RW. Induction of ovulation with clomiphene citrate (clomid) Obstet Gynecol Surv. 1965;20:873–900.
    1. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305–9.
    1. Wessman A, McArdle CR, Achiron R. Ultrasound in infertility. In: Machelle M, Seibel MD, editors. Infertility-a comprehensive text. 2nd ed. Stamford CT: Appleton and Lange; 1996. pp. 447–92.
    1. Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrozole and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination. 57th Annual Meeting of the American Society for Reproductive Medicine. Orlando, FL: 2001. (Abstract O-291) Fertil Steril. 2001;76(Suppl 1):S110.
    1. Ganesh A, Goswami SK, Chattopadhyay R, Choudhury K, Chakravarty B N. Comparison of letroz with continuous gonadotropins and clomiphene gonadotropin combination for ovulation induction. In 1387 PCOS women after clomiphene citrate failure: A randomized prospective clinical trial. J Assist Reprod Genet. 2009;26:19–24.
    1. Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Insulin resistance in metabolic syndrome in Indian PCOS South Asians. Indian J Endocrinal Metab. 2012;16:44–55.
    1. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990;5:670–4.
    1. Yagel S, Ben-Chetrit A, Anteby E, Zacut D, Hochner-Celnikier D, Ron M. The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil Steril. 1992;57:33–6.
    1. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: Effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993;59:756–60.
    1. Opsahl MS, Robins ED, O’Connor DM, Scott RT, Fritz MA. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril. 1996;66:533–9.
    1. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol. 1989;73:187–90.
    1. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, et al. Aandrogen receptor controlled ovarian hyperstimulation in the primate ovary: Cellular localization, regulation, and functional correlation. J Clin Endocrinol Metab. 1998;83:2479–85.
    1. Weil SJ, Vendola K, Zhou J, Bondy CA. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951–6.
    1. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bienre M, Bondy CA. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod. 1999;61:353–7.
    1. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgen stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622–9.
    1. Glintborg D, Menriksen JE, Andresen M, Hagen C, Hangaard J, Rasmussen PE, et al. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as referral diagnosis. Fertil steril. 2004;84:1570–9.
    1. Badawg A, Aal IA, Abulalta M. Climiphene Citrate or Letrozole for ovulation induction in women with polycystic ovarian syndrome: A prospective randomized trial. Fertil Steril. 2009;92:849–52.
    1. Bayar U, Tanriverdi HA, Aykut B, Ayoglu F, Ozcan O, Erdal K. Letrozole vs clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85:1045–8.
    1. Zeinalzadeh M, Basirat Z, Esmalpour M. Efficacy of letrozole in ovulation indication compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. J Reprod Med. 2010;55:36–40.
    1. Cortinez I, De Carvaiho D, Vantman F, Gabler G, Iniguez R, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril. 2005;83:110–5.
    1. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor on ovulatory function in normal women. Fertil Steril. 2002;78:280–5.
    1. Kilic-Okman T, Kucuk M, Altaner S. Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat. Fertil Steril. 2003;80:1330–2.
    1. Banerjee Ray P, Ray A, Chakroborti PS. Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Arch Gynecol Obstet. 2012;285:873–7.
    1. He D, Jiang F. Meta analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online. 2011;23:91–6.
    1. Begum MR, Ferdous J. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril. 2009;92:853–7.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever